George J. Lee, Ph.D. is a general partner and co-founder of AmKey Ventures, LLC, a venture management company specializing in investments in the biotech and pharmaceutical fields. AmKey Ventures has been dedicated to building a strong biotech portfolio in regions of the US and Asia over the last decade. Dr. Lee has extensive experience in the pharmaceutical industry having worked productively at a major pharmaceutical company (Syntex) for 13 years and early stage biomedical companies (Sonus and Shaman Pharmaceuticals) for 7 years. Dr. Lee is an internationally known pioneer in the field of steroid hormones research. His HPLC-RIA method has been recognized as the most accurate and sensitive method for the determination of trace amounts of steroid hormones in the complex biological matrices. Dr. Lee has in depth experience in analytical methods development and validation for New Drug Application (NDA) as well as various applications to the Food & Drug Administration. Dr. Lee earned his Ph.D. degree in chemistry from the State University of New York at Buffalo and his B.S. degree in agricultural chemistry from National Taiwan University, Taiwan.